{"altmetric_id":12496392,"counts":{"readers":{"mendeley":8,"citeulike":0,"connotea":0},"total":{"posts_count":4},"news":{"unique_users_count":3,"unique_users":["mpr","physicians_briefing","doctors_lounge"],"posts_count":4}},"citation":{"altmetric_jid":"4f6fa4f63cf058f610002f57","authors":["Bertram Pitt"],"doi":"10.1016\/j.jacc.2016.02.030","endpage":"1930","first_seen_on":"2016-10-08T01:29:16+00:00","isbns":[],"issns":["1558-3597","0735-1097"],"issue":"16","journal":"Journal of the American College of Cardiology (JACC)","last_mentioned_on":1462208410,"links":["http:\/\/content.onlinejacc.org\/article.aspx?articleID=2513807"],"pdf_url":"http:\/\/Content.onlinejacc.org\/data\/Journals\/JAC\/935209\/02030.pdf","pmid":"27102507","pubdate":"2016-04-26T00:00:00+00:00","publisher":"Journal of the American College of Cardiology","publisher_subjects":[{"name":"Cardiovascular Medicine And Haematology","scheme":"era"},{"name":"Public Health And Health Services","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"1928","subjects":["cardiology"],"title":"MRAs in Patients With AMI Without Early Evidence of Heart Failure","type":"article","volume":"67","mendeley_url":"http:\/\/www.mendeley.com\/research\/mras-patients-ami-without-early-evidence-heart-failure-time-reappraisal"},"altmetric_score":{"score":21,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":21},"context_for_score":{"all":{"total_number_of_other_articles":7639268,"mean":6.5692022176954,"rank":354144,"this_scored_higher_than_pct":95,"this_scored_higher_than":7282366,"rank_type":"exact","sample_size":7639268,"percentile":95},"similar_age_3m":{"total_number_of_other_articles":244140,"mean":12.505092394087,"rank":21308,"this_scored_higher_than_pct":91,"this_scored_higher_than":222684,"rank_type":"exact","sample_size":244140,"percentile":91},"this_journal":{"total_number_of_other_articles":6248,"mean":16.976644469345,"rank":905,"this_scored_higher_than_pct":85,"this_scored_higher_than":5314,"rank_type":"exact","sample_size":6248,"percentile":85},"similar_age_this_journal_3m":{"total_number_of_other_articles":276,"mean":42.623745454545,"rank":108,"this_scored_higher_than_pct":58,"this_scored_higher_than":161,"rank_type":"exact","sample_size":276,"percentile":58}}},"demographics":{"users":{"mendeley":{"by_status":{"Researcher":1,"Student  > Postgraduate":1,"Other":5,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":8}}}},"posts":{"news":[{"title":"Early MRA Use in Acute MI: Is It Beneficial?","url":"http:\/\/ct.moreover.com\/?a=26236876927&p=1pl&v=1&x=R16mvAS3a5OK8V5lyQ3PoQ","license":"public","citation_ids":[6932155,12496392,6932155],"posted_on":"2016-04-19T19:23:50+00:00","summary":"Share this article: MRA in addition to standard therapy does not improve outcome in setting of post-MI heart failure (HealthDay News) \u2014 For patients with post-myocardial infarction (MI) heart failure, mineralocorticoid receptor antagonists (MRAs) do\u2026","author":{"name":"MPR","url":"http:\/\/www.empr.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/567\/normal\/image.png?1392205523"}},{"title":"Mineralocorticoid Receptor Antagonists No Benefit Post MI","url":"http:\/\/ct.moreover.com\/?a=26235318474&p=1pl&v=1&x=Dbd4pelRGZthuGkVtv7iTw","license":"public","citation_ids":[6932155,12496392,6932155],"posted_on":"2016-04-19T16:46:08+00:00","summary":"(HealthDay News) -- For patients with post-myocardial infarction (MI) heart failure, mineralocorticoid receptor antagonists (MRAs) do not improve outcome, according to a study published in the April 26 issue of the Journal of the American College of\u2026","author":{"name":"Physician's Briefing","url":"http:\/\/www.physiciansbriefing.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/372\/normal\/logo.png?1436525474"}},{"title":"Mineralocorticoid Receptor Antagonists No Benefit Post MI","url":"http:\/\/ct.moreover.com\/?a=26235625201&p=1pl&v=1&x=wKBgBYQL34TAxNWcLSKkzw","license":"public","citation_ids":[6932155,12496392,6932155],"posted_on":"2016-04-19T17:14:56+00:00","summary":"(HealthDay News) -- For patients with post-myocardial infarction (MI) heart failure, mineralocorticoid receptor antagonists (MRAs) do not improve outcome, according to a study published in the April 26 issue of the Journal of the American College of\u2026","author":{"name":"Doctors Lounge","url":"http:\/\/www.doctorslounge.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/301\/normal\/Screen_Shot_2016-02-02_at_15.39.07.png?1454427565"}},{"title":"April 2016 Briefing - Pharmacy","url":"http:\/\/ct.moreover.com\/?a=26386574478&p=1pl&v=1&x=_gny_9BdvRYqQd9zMgGt_w","license":"public","citation_ids":[6744481,6744481,7043639,7041052,6665585,6665585,6968492,6972696,6976743,7034436,7034436,7033261,7033261,6967000,6955203,6850373,6850373,6955745,6955746,6954568,6954568,6950073,6950073,6867073,6867073,6867166,6949904,6949904,6906036,6906036,6906469,6781844,6781844,4704015,4704015,6864017,6864017,6898022,6787797,6783418,5098456,5098456,6861978,6861978,6863439,6579588,6579588,6841374,6818922,6818922,6832415,6462595,6462595,5780217,5780217,6794150,6794150,6838222,6786538,6818648,6818648,6596321,6596321,6932155,12496392,6786540,6563475,6563475,6819193,6819193,4699002,4699002,6530435,6530435,4822118,4822118,6656731,6656731,6711666,6711666,6735905,6718275,6718275,6722682,5024943,5024943,6564094,6564094,6656448,6656448,6656696,6558357],"posted_on":"2016-05-02T17:00:10+00:00","summary":"Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for April 2016.","author":{"name":"Doctors Lounge","url":"http:\/\/www.doctorslounge.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/301\/normal\/Screen_Shot_2016-02-02_at_15.39.07.png?1454427565"}}]}}